-+ 0.00%
-+ 0.00%
-+ 0.00%

BAYER’S KERENDIA® (FINERENONE) RECEIVES FDA APPROVAL AS THE FIRST NEW TREATMENT IN 30 YEARS FOR ADULTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 1 DIABETES

Reuters·09/17/2026 06:30:00

Please log in to view news